Andy Skibo
Head of Global Biologics Operations & Global Engineering, AstraZeneca/Medimmune
Meet Andy Skibo
“I am passionate about ensuring that we (both AstraZeneca/MedImmune specifically, and our biopharmaceutical industry as a whole) have a long-range biologics supply capability,” says Andy. He would like to see the pharma industry work closer with regulatory agencies to find ways to dramatically reduce the cost of developing new drugs – specifically the cost of clinical trials – without sacrificing product safety or affecting patient risks.